XML 94 R7.htm IDEA: XBRL DOCUMENT v3.20.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Cash flows from operating activities:    
Net income (loss) $ 18,412 $ (42,047) [1]
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation and amortization 25,533 29,359
Intangible asset impairment charge 189
Amortization and write-off of debt issuance costs 1,005 1,451
Unrealized gain related to interest rate swaps 44 (201)
Fixed asset impairment charge 274 42,860
Other impairment charge (Note 12) 2,202 10,019
Gain on sale of assets (453) (149)
Gain on sale of unconsolidated affiliate (2,225)
Equity-based incentive compensation 973 1,845
Changes in assets and liabilities:    
Decrease (increase) in accounts receivable 9,325 (25,452)
Decrease (increase) in receivables from related parties (67) 2,027
Decrease in other current assets 2,628 3,399
Decrease in other non-current assets 2,964 442
Decrease in accounts payable (702) (592)
Increase (decrease) in payables to related parties (282) 342
Decrease in accrued interest payable (172) (229)
Increase in accrued property taxes 158 1,031
Increase (decrease) in accrued payroll 1,156 (2,452)
Decrease in other accrued liabilities (3,579) (1,500)
Net cash provided by operating activities 49,837 48,784
Cash flows from investing activities:    
Acquisitions (21,959)
Capital expenditures (12,746) (34,400)
Proceeds from sale of assets 8,410 5,051
Proceeds from sale of unconsolidated affiliate 2,225
Net cash provided by (used in) investing activities (4,336) 39,455
Cash flows from financing activities:    
Payments on other financing activities (2,586) (2,550)
Debt issuance costs (358)
Borrowings under credit agreement 291,000 324,000
Payments under credit agreement (301,000) (366,000)
Proceeds from equity issuance 176 208
Capital contributions 183
Distributions (33,988) (44,736)
Net cash used in financing activities (46,398) (89,253)
Net decrease in cash and cash equivalents (897) (1,014)
Cash and cash equivalents at beginning of period 1,455 2,469
Cash and cash equivalents at end of period 558 1,455
Supplemental disclosure of non-cash financing and investing cash flow information:    
Non-cash changes in property, plant and equipment 1,590 (715)
Increase in accrued liabilities related to insurance premium financing agreement 2,356 2,184
Cash paid for interest, net of amounts capitalized 15,150 16,088
Cash paid for income taxes 227 133
Ergon [Member]    
Cash flows from investing activities:    
Proceeds from sale of assets 88,538
Supplemental disclosure of non-cash financing and investing cash flow information:    
Non-cash change in assets and liabilities due to settlement items related to the sale of terminal assets to Ergon (1,308)
Third Party [Member]    
Changes in assets and liabilities:    
Increase (decrease) in accrued crude oil purchases (7,243) 13,949
Increase (decrease) in unearned revenue (1,961) 785
Related Party [Member]    
Changes in assets and liabilities:    
Increase (decrease) in accrued crude oil purchases 1,588 10,219
Increase (decrease) in unearned revenue $ (1,966) $ 5,714
[1] Operating loss and net loss for the fourth quarter and full year 2018 are impacted by asset impairment charges of $52.4 million and $53.1 million, respectively.